Skip to main content
Clinical Trials/ACTRN12607000285459
ACTRN12607000285459
Completed
Phase 3

A randomised trial of effective and cost effectiveness of supervised versus unsupervised administration of buprenorphine-naloxone for heroin dependence

angton Centre0 sites146 target enrollmentMay 29, 2007

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
angton Centre
Enrollment
146
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 29, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
angton Centre

Eligibility Criteria

Inclusion Criteria

  • DSM\-IV diagnosis of heroin dependence. 12 month history of dependence. Stable housing.

Exclusion Criteria

  • Dependence on alcohol, amphetamines, or benzodiazepines.Major medical or psychiatric conditions. Methadone or buprenorphine treatment in the past month. Risk of incarceration.Pregnant/planning pregnancy. Previous enrolment in study.

Outcomes

Primary Outcomes

Not specified

Similar Trials